Innovaccer Inc., a leading healthcare technology company, has closed a new round of growth funding at a $1.3 billion post-money valuation, led by Tiger Global Management. Existing investors Steadview Capital, Dragoneer, B Capital Group, Mubadala Capital, and M12 (Microsoft s Venture Fund) participated in the round, as well as new investor OMERS Growth Equity. This is the company’s first financing announcement since its Series C round, bringing the total capital raised to over $225 million. It was valued at $350 million during its Series C round of $70 million in February last year. The firm didn’t mention the amount, but according to the sources, it has raised about $105 million in this funding round. With its additional funding, San Francisco-based Innovaccer which has offices in India is launching the Innovaccer Health Cloud. The platform-as-a-service offering combines the company’s data activation platform and application suite with an extensive set of platform services
LUNG cancer is one of the most common and serious types of cancer, with around 47,000 people diagnosed with the condition every year in the UK. Bronchitis that doesn t go away is an early warning sign.
FAIRFIELD-SUISUN, CALIFORNIA
Lisa Oney juggles her chemotherapy treatment bag on her right shoulder and three-month-old Jack ODriscoll in her left arm while daughter Fiona ODriscoll, 3, has a snack in the kitchen. Lisa was getting her chemotherapy treatment at her Souderton, Pa. home on Jan. 16, 2021. Penn Medicine has ramped up doing some forms of chemotherapy at home instead of in the hospital or in an infusion center. (Elizabeth Robertson/Philadelphia Inquirer/TNS)
Cancer treatment tackles a new frontier: Chemo at home, even on the go
PHILADELPHIA – As she fights cancer, Lisa Oney is not shackled to a hospital bed for days at a time, stuck there while she is infused with chemotherapy drugs.
Written by Christopher Curley on February 17, 2021 Fact checked by Maria Gifford
Scientists say the way a COVID-19 vaccine stimulates the body’s immune system could be used in a potential cancer vaccine. Joan Slatkin/Education Images/Universal Images Group via Getty Images
Scientists are exploring ways to use the messenger RNA (mRNA) technology deployed in the COVID-19 vaccines as a way to fight cancer.
Experts say mRNA can stimulate the body’s immune system to recognize cancer cells and attack them.
They note that there are many different types of cancer, so any vaccine would need to be versatile.
All data and statistics are based on publicly available data at the time of publication. Some information may be out of date. Visit our coronavirus hub and follow our live updates page for the most recent information on the COVID-19 pandemic.